Drug application
CARMUSTINE (CARMUSTINE)
Drugs@FDA ANDA 214814 · MSN
Key facts
| Drug name | CARMUSTINE |
|---|---|
| Active ingredients | CARMUSTINE |
| Application type | ANDA |
| Application number | 214814 |
| Company | MSN |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 100MG/VIAL |
| Marketing status | Prescription |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | May 11, 2023 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.